The Centers for Medicare and Medicaid Services (CMS) has established the final HCPCS coding, benefit category determination, and payment determination for eXciteOSA, a daytime therapy for obstructive sleep apnea (OSA) by Signifier Medical Technologies.
“This milestone accelerates our mission to improve patients’ lives by offering innovative and effective treatment options,” says Signifier Medical director and co-founder Akhil Tripathi in a release. “Demand is growing, with over 12,000 patients who have sought our therapy, and reimbursement will now help even more patients who suffer from OSA.”
The recent CMS HCPCS Level II coding decision became effective on Oct 1. Here is the complete list of available codes for eXciteOSA:
E0490
Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote.
K1028
Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application.
E0491
Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply.
K1029
Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply.
Used for 20 minutes per day during the initiation period, and then twice per week thereafter for maintenance, eXciteOSA targets a primary root cause of mild OSA by delivering neuromuscular electric stimulation to increase tongue muscle endurance.
